Neurofeedback helps reduce 'Chemofog'
What my colleagues and I have been saying for quite some time is now being supported by independent research findings about the value of brainwave biofeedback training as a way to reduce neuroinflammation resulting from chemotherapy. Women being treated for breast cancer engaged in neurofeedback training 3 times a week for up to 9 weeks for a total of 18, 30-minute training sessions. Quantitative EEG and neuropsychological testing was done before and after the training sessions were completed and indicated significant improvement in a range of cognitive and executive function measures. The sample size is too small to draw conclusions but is compelling enough to warrant larger studies. Quietmind Fdn. IRB reviewed a study conducted in 2013 by Jean Alvarez and her colleagues using neurofeedback for breast cancer patients using a different method of neurofeedback and similar results were obtained. We're encouraged to see these findings now coming out of a major academic research university and hope that it will lead to larger trials and hopefully FDA approval and insurance reimbursement.
Your comment will be posted after it is approved.
Leave a Reply.
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.